AI assistant
Sending…
Aptevo Therapeutics Inc. — Director's Dealing 2019
Jun 26, 2019
35422_dirs_2019-06-25_eb83589b-64b6-4b94-ad31-73c462a6cfd2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2019-06-25
Reporting Person: Abdun-Nabi Daniel (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-06-25 | Common Stock | P | 16667 | $0.9 | Acquired | 109351 | Direct |
More from Aptevo Therapeutics Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Feb 19
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Jan 30
Regulatory Filings
2026
Jan 28
Proxy Solicitation & Information Statement
2026
Jan 26